European Regulatory Strategy ‘Should Prioritize Real World Evidence’
Innovative Clinical Trials Should Be Priority Too, Says EFPIA.
EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.
